Soleus Capital Management, L.P. has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $1.22 Billion distributed in 91 stocks.

Among their holdings, we can observe that their the top five positions include companies like: United Therapeutics Corp with a value of $59.7M, Edap Tms Sa with a value of $53.1M, Iovance Biotherapeutics, Inc. with a value of $51.9M, Teva Pharmaceutical Industries LTD with a value of $49.2M, and Tg Therapeutics, Inc. with a value of $48.2M.

Examining the 13F form we can see an increase of $447M in the current position value, from $776M to 1.22B.

Soleus Capital Management, L.P. is based out at Greenwich, CT

Below you can find more details about Soleus Capital Management, L.P. portfolio as well as his latest detailed transactions.

Portfolio value $1.22 Billion
Healthcare: $1.01 Billion
ETFs: $209 Million
Consumer Defensive: $754,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 91
  • Current Value $1.22 Billion
  • Prior Value $776 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 31 stocks
  • Additional Purchases 28 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 24 stocks
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.